إعلان
إعلان

NEO

NEO logo

NeoGenomics, Inc.

12.95
USD
برعاية
+0.12
+0.94%
٠٩ يناير, ١٣:٢٠ UTC -5
مفتوح

تقارير أرباح NEO

النسبة الإيجابية المفاجئة

NEO تفوق 35 من 40 آخر التقديرات.

88%

التقرير التالي

بيانات التقرير القادم
١٦ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$190.14M
/
$0.03
التغير الضمني من Q3 25 (Revenue/ EPS)
+1.25%
/
--
التغير الضمني من Q4 24 (Revenue/ EPS)
+10.55%
/
-25.00%

NeoGenomics, Inc. earnings per share and revenue

On ٢٨ أكتوبر ٢٠٢٥, NEO reported earnings of 0.03 USD per share (EPS) for Q3 25, beating the estimate of 0.02 USD, resulting in a 40.85% surprise. Revenue reached 187.80 مليون, compared to an expected 185.61 مليون, with a 1.18% difference. The market reacted with a -2.36% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 المحللين forecast an EPS of 0.03 USD, with revenue projected to reach 190.14 مليون USD, implying an زيادة of 0.00% EPS, and زيادة of 1.25% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, NeoGenomics, Inc. reported EPS of $0.03, beating estimates by 40.85%, and revenue of $187.80M, 1.18% above expectations.
The stock price moved down -2.36%, changed from $10.16 before the earnings release to $9.92 the day after.
The next earning report is scheduled for ١٦ فبراير ٢٠٢٦.
Based on 15 المحللين, NeoGenomics, Inc. is expected to report EPS of $0.03 and revenue of $190.14M for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان